Beraprost Impurity 36(CAS: 13865-19-5)

Beraprost Impurity 36 (CAS: 13865-19-5) is a byproduct of the synthesis of the drug beraprost, which is used to treat pulmonary arterial hypertension. It is a prostaglandin derivative with similar pharmacological properties but lower efficacy.

Beraprost Impurity 36 (CAS: 13865-19-5) is primarily used in the pharmaceutical industry as a starting material or intermediate in the synthesis of beraprost. It may also be used for research purposes to study prostaglandin derivatives.

Beraprost Impurity 36 (CAS: 13865-19-5) is considered safe when handled with appropriate precautions. It is non-toxic but should be used in a well-ventilated area to avoid inhalation. Protective gloves and goggles are recommended to prevent skin and eye contact.

Beraprost Impurity 36 (CAS: 13865-19-5) should be stored in a cool, dry place away from direct sunlight and heat sources. It should be kept in a tightly sealed container to prevent degradation. Storage at room temperature is recommended to ensure stability.